Encompass Health Files For Mixed Shelf Offering, Size Not Disclosed
- Sec Filing
Read original at benzingaStocks · News reference
Payable on Oct. 15, 2026, to holders of record on Oct. 1, 2026.
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
- Sec Filing
Read original at benzingaEncompass Health's EVP and general counsel John Patrick Darby sold 8,906 shares (11% of his direct holdings) for $1.1 million on August 10, 2026, following strong earnings and a stock rally. The sale comes after the company raised guidance due to a favorable 2.3% Medicare rate increase for inpatient rehabilitation services starting in October. While multiple insiders trimmed positions after the earnings-driven rally, the article emphasizes that Medicare reimbursement rates are the key factor for investors to monitor, as they directly impact the company's pricing and profitability.
Read original at the-motley-foolEncompass Health's CFO Douglas Coltharp sold 18,869 shares worth $2.4 million on August 10, reducing his direct stake by 27% but maintaining a total beneficial ownership of 241,000 shares valued at $30.4 million. The sale occurred the same day as the CEO's larger stake reduction, following strong Q2 earnings that included 10% revenue growth, raised full-year guidance, and increased dividend/buyback authorization.
Read original at the-motley-foolFiled: 2026-08-13 AccNo: 0000785161-26-000195 Size: 139 KB Item 8.01: Other Events
Read original at edgar